ABRAMS: You are right that we do not want to see trials that a lot of time and effort has been put into, and patients have joined, and then don’t meet their enrollment goals. We have to do more, and we’ve recognized that.
To access this subscriber-only content please log in or renew your subscription.
Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.
Login Subscribe
Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.
Login Subscribe